(MedPage Today) — The BMJ slapped an “expression of concern” on a much-publicized stem cell trial it published just 2 weeks ago.
A boxed warning now lies at the top of the phase III study, PREVENT-TAHA8, which had reported that an intracoronary…
Source link : https://www.medpagetoday.com/publichealthpolicy/stemcellresearch/118484
Author :
Publish date : 2025-11-12 22:05:00
Copyright for syndicated content belongs to the linked Source.
